CIK 0001971532 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Telomir Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TELO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- operating
- EIN
- 872606031
- Phone
- 786-396-6723
- Business address
- 100 SE 2ND ST, SUITE 2000 #1009, MIAMI, FL, 33131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-27 | Aminov Erez CEO & Chairman | Grant or award · Incentive Stock Options (right to buy) | +1,960,170 | 1,960,170 | ||
| 2024-08-27 | Del Giudice Matthew Paul Director | Grant or award · Incentive Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2024-08-27 | Whalen Matthew Pratt Director | Grant or award · Incentive Stock Options (right to buy) | +25,000 | 25,000 | ||
| 2024-02-13 | Bay Shore Trust 10% owner | Purchase | +49,000 | $7.00 | $343K | 5,455,431 |
| 2024-02-13 | Bay Shore Trust 10% owner | Purchase | +40,000 | $7.00 | $280K | 1,365,646 |
| 2024-02-13 | Bay Shore Trust 10% owner | Purchase | +49,000 | $7.00 | $343K | 1,902,659 |
Page 2 of 2 · 26 trades